Cormedix Inc (STU:19KA)
€ 9.65 0.25 (2.66%) Market Cap: 601.04 Mil Enterprise Value: 558.66 Mil PE Ratio: 0 PB Ratio: 10.17 GF Score: 52/100

CorMedix Inc. - Special Call Transcript

Mar 09, 2021 / 01:30PM GMT
Release Date Price: €6.3 (+9.57%)
Operator

Greetings. Welcome to the CorMedix Conference Call. (Operator Instructions) Please note, this conference is being recorded. I'll now turn the conference over to Dan Ferry from LifeSci Advisors. Dan, you may begin.

Daniel Ferry
LifeSci Advisors, LLC - MD & Relationship Manager

Good morning, and welcome to the CorMedix Management Update Call. Leading the call today is Khoso Baluch, Chief Executive Officer of CorMedix. He is joined by Dr. Phoebe Mounts, Executive Vice President and General Counsel; and Dr. Matt David, Executive Vice President and Chief Financial Officer; and Mr. Jack Armstrong, Executive Vice President for Technical Operations.

Before we begin, I would like to remind everyone that during the call, management may make what are known as forward-looking statements within the meanings set forth in the Private Securities Litigation Reform Act of 1995. These statements are subject to certain risks and uncertainties and include, but are not limited to, any of the following: Any statements other than statements of historical fact regarding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot